Clinical Trial

Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer

Study acronym: RETURN
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 26, 2023 (before its estimated October 2023 completion). Its status may not reflect the trial's current state.
Summary
On the basis of the now consolidated literature and clinical experience of focal therapies, the execution of partial prostatectomy/hemiprostatectomy with robot-assisted laparoscopic technique can be proposed in a well-selected cohort of patients. The hypothesis is that with this technique it is possible to achieve excellent levels of disease control, in terms of positive surgical margins (PSM) and biochemical recurrence of the disease (BCR), against a minimal impact as regards postoperative functional outcomes (continence and sexual power).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-04-16.
Trial Details
NCT Number NCT05832736
Lead Sponsor Fondazione del Piemonte per l'Oncologia
Conditions Prostate Cancer
Enrollment 36 participants
Start Date 2023-04-12
Primary Completion 2023-10 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2023-09-26